The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Editas Medicine Inc’s stock clocked out at $1.26, down -5.97% from its previous closing price of $1.34. In other words, the price has decreased by -$5.97 from its previous closing price. On the day, 2.53 million shares were traded. EDIT stock price reached its highest trading level at $1.33 during the session, while it also had its lowest trading level at $1.23.
Ratios:
To gain a deeper understanding of EDIT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.75 and its Current Ratio is at 3.75. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.13.
Stifel Downgraded its Buy to Hold on December 13, 2024, whereas the target price for the stock was revised from $11 to $3.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 03 ’24 when O’Neill Gilmore Neil sold 1,618 shares for $2.08 per share. The transaction valued at 3,361 led to the insider holds 312,106 shares of the business.
Mei Baisong sold 541 shares of EDIT for $1,124 on Dec 03 ’24. The EVP, CHIEF MEDICAL OFFICER now owns 133,354 shares after completing the transaction at $2.08 per share. On Sep 04 ’24, another insider, Mei Baisong, who serves as the EVP, CHIEF MEDICAL OFFICER of the company, sold 518 shares for $3.42 each. As a result, the insider received 1,774 and left with 133,895 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EDIT now has a Market Capitalization of 104010600 and an Enterprise Value of -122589392. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.68 while its Price-to-Book (P/B) ratio in mrq is 0.59. Its current Enterprise Value per Revenue stands at -1.985 whereas that against EBITDA is 0.551.
Stock Price History:
The Beta on a monthly basis for EDIT is 1.94, which has changed by -0.85730463 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, EDIT has reached a high of $11.58, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is -40.50%, while the 200-Day Moving Average is calculated to be -69.54%.
Shares Statistics:
It appears that EDIT traded 2.64M shares on average per day over the past three months and 3003420 shares per day over the past ten days. A total of 82.54M shares are outstanding, with a floating share count of 81.78M. Insiders hold about 0.93% of the company’s shares, while institutions hold 67.79% stake in the company. Shares short for EDIT as of 1734048000 were 16929351 with a Short Ratio of 6.90, compared to 1731628800 on 15905551. Therefore, it implies a Short% of Shares Outstanding of 16929351 and a Short% of Float of 25.979999999999997.
